CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Avidity Biosciences Fiscal Q4 2023 Earnings Report | CapyFin

Avidity Biosciences

RNAM · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 in 4d Q3 2025 +1.26%Q2 2025 -2.72%Q1 2025 -0.63%Q4 2024 +5.36%Q3 2024 -1.10%Q2 2024 +6.23%Q1 2024 -0.38%Q4 2023 +19.53%Q3 2023 -6.00%Q2 2023 +6.01%Q1 2023 +3.96%Q4 2022 +5.55%Q3 2022 +5.66%Q2 2022 +0.15%Q1 2022 -9.40%Q4 2021 +0.88%Q3 2021 -0.54%Q2 2021 -1.39%Q1 2021 -12.53%Q4 2020 +7.53%Q3 2020 -1.02%Q2 2020 +1.91%Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019

Feb 28, 2024

•

Dec 31, 2023

Avidity Biosciences Q4 2023 Earnings Report

Previous year: $2.77M

Previous year: -$0.88

Research and development expenses

General and administrative expenses

Previous year: $2.39M

Cash and Equivalents

Previous year: $340M

Previous year: -$40M

Previous year: $639M

Avidity Biosciences

Unlock previous datapoints

Avidity Biosciences

Unlock previous datapoints

Revenue by Segment

Collaboration Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Avidity Biosciences

Avidity Biosciences Revenue by Segment